We also found that chromic oral treatment with a ciliary neurotrophic factor (CNTF) derived peptidergic compound (P021) to 3×Tg-AD mice can reduce Aβ production and rescue deficits in cognition, neurogenesis, and synaptic plasticity in 3×Tg-AD mice [43]. This evidence concerns the gene CNTF and Alzheimer disease.